MiR-17-5p and MKL-1 modulate stem cell characteristics of gastric cancer cells

Zhou-Tong Dai1, Yuan Xiang2, Yuan-Yuan Duan1

  • 1Institute of Biology and Medicine, College of Life and Health Sciences, Wuhan University of Science and Technology, Hubei, 430081, P.R. China.

Insights

This study reveals microRNA miR-17 and MKL-1 promote gastric cancer stem cell properties. Targeting these may offer new therapeutic strategies for gastric cancer.

Area of Science:

  • Molecular Oncology
  • Cancer Stem Cell Biology
  • Gastric Cancer Research

Background:

  • Targeting cancer stem cells (CSCs) holds significant therapeutic promise for cancer treatment.
  • The roles of microRNA (miRNA) and epithelial-mesenchymal transition (EMT) in regulating CSC characteristics are well-established.
  • The specific involvement of miR-17 and MKL-1 in gastric CSCs remained unexplored.

Purpose of the Study:

  • To investigate the mechanism of miR-17 and MKL-1 in gastric cancer stem cells.
  • To explore the potential of miR-17 and MKL-1 as therapeutic targets in gastric cancer.

Main Methods:

  • Utilized RT-PCR, Western Blot, flow cytometry, and immunofluorescence for cellular analysis.
  • Employed sphere formation assays, xenograft tumor models, and drug resistance tests in vitro and vivo.
  • Verified MKL-1 targets (CD44, EpCAM, miR-17-5p promoter) using luciferase assays and ChIP.

Main Results:

  • miR-17-5p and MKL-1 were confirmed to promote stem cell-like properties in gastric cancer.
  • MKL-1 was found to target the promoters of CD44, EpCAM, and miR-17-5p.
  • TCGA database analysis showed increased miR-17-5p and MKL-1 in gastric cancer, with higher MKL-1 correlating with reduced survival.

Conclusions:

  • Identified a novel regulatory pathway involving miR-17 and MKL-1 in gastric CSCs.
  • These findings provide new insights into potential early diagnosis and molecular therapies for gastric cancer.
  • MKL-1 promotes gastric cancer progression by targeting miR-17, CD44, and EpCAM.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K